Keywords: nexmed, nail, fungus, lacquer, passes, ph, developer

NexMed's nail fungus lacquer passes Ph I

Article | 05 September 2005

NexMed, a developer of innovative treatments utilizing its NexACT drug delivery technology, says that results from a safety and pharmacokinetics ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Lamisil

Terbinafine

Nystatin

Go to drug listing